This product is provided by the company SETPA TIBBİ GEREÇLER İTHALAT İHRACAT SAN. VE TİC. LTD. ŞTİ.
. Please contact for more information.
Product Description
NEOLACT® PGLA:
NEOLACT® PGLA, is a sterile, synthetic, braided and coated surgical suture material made of 90% Glycolic Acid + 10% Lactic Acid. It is dyed in FDA approved (D&C Violet No.2) to make it easily distinguishable. It is non-antigenic and nonpyrogenic. NEOLACT® PGLA has a reliable and predictable absorption profile, as well as having very high initial tensile and knot-pull strength. The braided threads are coated with PGLA 37 (30% Glycolic Acid + 70% Lactic Acid) and Calcium Stearate.
NEOLACT® PGLA retains approximately 75% of its initial tensile strength on 14th day of its application and has approximately 50% of its initial tensile strength on day 21. It provides wound support for up to 28 days. In normal perfusion of tissues, NEOLACT® PGLA\’s absorption is essentially completed between 56-70 days.
NEOLACT® RAPID PGLA:
NEOLACT® RAPID PGLA, is a sterile, synthetic, braided and coated surgical suture material made of 90% Glycolic Acid + 10% Lactic Acid, degraded for quicker absorption. The thread is undyed, therefore beige in color. It is non-antigenic and non-pyrogenic. NEOLACT® RAPID PGLA has a reliable and predictable absorption profile, as well as having very high initial tensile and knot-pull strength. The braided threads are coated with PGLA 37 (30% Glycolic Acid + 70% Lactic Acid) and Calcium Stearate.
NEOLACT® RAPID PGLA retains approximately 50% of its initial tensile strength on 7 day post implantation and provides effective wound support for 7 to 10 days. It loses all of its tensile strength between 10 - 14 days. In normal perfusion of tissues, NEOLACT® RAPID PGLA\’s absorption is completed in approximately 42 days.